Home › Funds › Opaleye Management Inc. › IRD

Opaleye Management Inc. position in IRD

OPUS GENETICS INC · Health Care

Opaleye Management Inc. reported holding 1,125,000 shares of IRD (OPUS GENETICS INC) in its Q2 2026 13F filing — a position valued at US$4.6M, representing 0.42% of its reported portfolio and ranking #36 among its reported holdings. Opaleye Management Inc. has disclosed IRD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.12M sh
Reported value held$4.62M
Portfolio Weight0.42%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s IRD position evolved

Opaleye Management Inc. first disclosed a stake in IRD in Q1 2025 at 1,175,000 shares (US$1.5M). The position peaked in Q2 2026 at 1,125,000 shares, worth US$4.6M. Across 6 filings, Opaleye Management Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,125,000 shares valued at US$4.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.18M $1.55M New
Q2 2025 1.22M $1.15M Add
Q3 2025 1.10M $1.81M Reduce
Q4 2025 1.12M $2.25M Add
Q1 2026 1.12M $2.25M Hold
Q2 2026 1.12M $4.62M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRD and 13F data

IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRD

All IRD fund holders →

FAQ

How long has Opaleye Management Inc. held IRD?

Opaleye Management Inc. has disclosed IRD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Opaleye Management Inc.'s current position in IRD?

As of Q2 2026, Opaleye Management Inc. holds 1.12M shares of IRD (OPUS GENETICS INC), valued at $4.62M, representing 0.42% of its reported portfolio and ranking #36.

Has Opaleye Management Inc. been buying or selling IRD?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in IRD. The position peaked in Q2 2026 at 1.12M shares.

Which other funds hold IRD?

Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.